Peter Blume-Jensen
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Acrivon Therapeutics, Inc. (ACRV) | M.D., Ph.D. Chief Executive Officer, President and Director | $709,893 | $2,718,538 |
| 2024 | Acrivon Therapeutics, Inc. (ACRV) | M.D., Ph.D. Chief Executive Officer, President and Director | $655,133 | $2,000,312 |
| 2023 | Acrivon Therapeutics, Inc. (ACRV) | M.D., Ph.D. Chief Executive Officer, President and Director | $629,000 | $6,465,973 |
| 2022 | Acrivon Therapeutics, Inc. (ACRV) | M.D., Ph.D. Chief Executive Officer, President and Director | $535,942 | $21,685,240 |
| 2021 | Acrivon Therapeutics, Inc. (ACRV) | M.D., Ph.D. Chief Executive Officer, President and Director | $430,000 | $756,771 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.